Urotensin Ⅱ increases 5-Lipoxygenase expression on monocytes via an activation of UT-ROS-Akt pathway

来源 :Ready for 2018- the 4th China International Forum on Hyperte | 被引量 : 0次 | 上传用户:zm850311
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Aims:Urotensin Ⅱ (Ull) is the most potent vasoactive peptide identified to date.Serum urotensin Ⅱ levels elevated in non-dipper hypertensive patients.Human urotensin Ⅱ promotes hypertension.Moreover,increased levels of urotensin Ⅱ levels are correlated with carotid atherosclerosis in essential hypertensive patients.Atherosclerosis is an inflammatory process associated with several pathophysiological reactions within the vascular wall.The events involved in early atherosclerosis is vascular dysfunction or injury and monocyte recruitment.UII had a chemoattractant effect on cultured monocytes.It is well established that luekotriene B4(LTB4) is a potent chemoattractant, facilitating leucocyte adhesion and recruitment.LTB4 is a metabolite of arachidonic acid through the 5-Lipoxygenase(5-LO) pathway.The aim of this study was to explore the potential role for Ull in 5-LO expression and to investigate the molecular mechanisms of 5-LO expression in UII-stimulated RAW264.7 macrophages.
其他文献
会议
会议
会议
会议
会议
会议
会议
会议
  Objective:To investigate the relationship between hypertension and single nucleotide polymorphism of three genes whose productions regulate the water and so
会议
会议